Setting
the Scene | Background
| The Trip | South
Africa | Botswana
| Uganda | Exiting
the Scene


Dr. Khan’s presentation provided a clear
understanding of why there were so many efforts underway
in Botswana. HIV/AIDS is having a devastating impact on
her country and Botswana’s needs are pressing and immediate.
When asked about the role of ABC, as in the Ugandan model
(Abstinence, Be Faithful, Use a Condom),
Dr. Khan said Uganda had reason to promote ABC because it
had been devastated by wars and other crises. Botswana had
no such history of living through a crisis, so the people
of Botswana do not know how to problem solve as a country.
In Uganda, they do. As a result, the government has had
to develop ways to reach the people living with HIV/AIDS
and begin a program of behavior change. Instead of working
directly on HIV, the government has looked at things around
HIV and focused on addressing those things. Education, community
development, housing development, improvements in the standard
of living — if the government can extend life expectancy
and enhance social well-being it will have a mitigating
impact on the epidemic.
We spent the next day at the Princess
Marina Hospital. Princess Marina, the principal hospital
in Botswana, is home to the country’s leading HIV/AIDS efforts,
including the Children’s Center of Excellence coordinated
in partnership with Baylor University Medical School and
Bristol Meyer Squibb, the ARV Clinic supported by ACHAPS
and Gates, and the Harvard Reference Laboratory. The Children’s
Center, our first stop, opened during the summer of 2003
(just a few weeks before our visit) and was visited by First
Lady Laura Bush in July 2003 and Princess Anne in July 2003.
It is staffed by health professionals from the U.S. and
Botswana who provide state of the art care and treatment
for HIV-positive children and their families in a state-of-the-art
facility. The Center provides comprehensive primary and
specialty medical care for infants, children, and families;
training for health professionals; and clinical research.
Baylor College of Medicine, through a program funded by
NIH/Fogarty International Center, is a collaborative partner
in this effort.
|